Related Experiment Video
Updated: Dec 21, 2025
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.7K
Respiratory failure in patients infected with SARS-CoV-2
Rishik Vashisht1, Abhijit Duggal2
1Department of Critical Care, Respiratory Institute, Cleveland Clinic.
Cleveland Clinic Journal of Medicine
|May 16, 2020
Summary
Managing COVID-19 patients with acute respiratory distress syndrome (ARDS) requires identifying respiratory failure causes and using lung-protective mechanical ventilation. Preventing coronavirus spread is crucial for these critically ill patients.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Infectious Diseases
Background:
- COVID-19 frequently causes severe acute respiratory distress syndrome (ARDS) in intensive care unit (ICU) patients.
- Mechanical ventilation is required for nearly 90% of these patients, leading to high morbidity and mortality.
- Management necessitates addressing respiratory failure causes and infection control.
Purpose of the Study:
- To outline best practices for managing COVID-19 patients with ARDS.
- To emphasize the importance of lung-protective ventilation strategies.
- To highlight the need for differential diagnosis of respiratory failure.
Main Methods:
- Review of current guidelines for ARDS management.
- Focus on supportive care including oxygen supplementation and mechanical ventilation.
- Emphasis on low-tidal-volume, lung-protective ventilation protocols.
Main Results:
- COVID-19 ARDS management requires a multi-faceted approach.
- Lung-protective ventilation is a cornerstone of care for these patients.
- Identifying and treating underlying causes of respiratory failure is essential.
Conclusions:
- Effective management of COVID-19 ARDS hinges on prompt diagnosis and adherence to lung-protective ventilation.
- Supportive care and infection prevention are critical for improving outcomes.
- Continuous evaluation for alternative causes of respiratory failure is necessary.
More Related Videos
Related Concept Videos
01:30Acute Respiratory Failure-III
656
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
656
01:21Acute Respiratory Failure-I
695
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
695
01:29Acute Respiratory Failure-V
369
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
369
01:21Acute Respiratory Failure-II
906
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
906
01:23Acute Respiratory Failure-IV
450
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
450
01:30Pneumonia III: Complications and Assessment
699
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
699